BRENDA SHANLEY: Open Payments
NPI 1083639207 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 6 payments from 4 companies in 2025. Trend: 2023 $101 · 2024 $164 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Lundbeck LLC | 1 | $20 |
Products named: AUSTEDO XR, UZEDY, INGREZZA, CAPLYTA, REXULTI.
Industry payments across WA — which companies pay providers there.
